Artificial Intelligence (AI) is transforming the field of drug development, offering novel insights and efficiencies in the analysis of drug dynamics, system-wide pharmacological impacts, and physiological processes. This Special Issue is dedicated to exploring the convergence of AI with pharmacokinetic/pharmacodynamic (PK/PD) modeling, quantitative systems pharmacology (QSP), and physiologically-based pharmacokinetic (PBPK) modeling, emphasizing how this synergy can streamline and enhance drug development.
We aim to gather contributions that:
- Demonstrate how AI is revolutionizing PK/PD, QSP, and PBPK modeling.
- Present empirical and theoretical research that showcases the application of AI in these areas.
- Evaluate the implications of AI-driven technologies for future pharmaceutical research and clinical practice.
Our objective is to curate a collection of articles that not only provide scientific advancement but also practical insights into the application of AI in drug development.
Keywords:
AI, drug development, pharmacokinetics, pharmacodynamics
Artificial Intelligence (AI) is transforming the field of drug development, offering novel insights and efficiencies in the analysis of drug dynamics, system-wide pharmacological impacts, and physiological processes. This Special Issue is dedicated to exploring the convergence of AI with pharmacokinetic/pharmacodynamic (PK/PD) modeling, quantitative systems pharmacology (QSP), and physiologically-based pharmacokinetic (PBPK) modeling, emphasizing how this synergy can streamline and enhance drug development.
We aim to gather contributions that:
- Demonstrate how AI is revolutionizing PK/PD, QSP, and PBPK modeling.
- Present empirical and theoretical research that showcases the application of AI in these areas.
- Evaluate the implications of AI-driven technologies for future pharmaceutical research and clinical practice.
Our objective is to curate a collection of articles that not only provide scientific advancement but also practical insights into the application of AI in drug development.
Keywords:
AI, drug development, pharmacokinetics, pharmacodynamics